Postfusion glycoprotein F0/post-F protein (RSV)

Postfusion glycoprotein F0/post-F protein (RSV) Product List

  • Product Category

    Protein (2)Antibody (2)

  • Product Status

    Launched (4)

  • Species

    Human respiratory syncytial virus A (strain A2) (1)Human respiratory syncytial virus B (strain B1) (1)Mouse (2)

  • Tag

    His Tag (2)- (2)

  • Conjugate

    Unconjugated (4)

Postfusion glycoprotein F0/post-F protein (RSV) Background

Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
RGN-259Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4Phase 3 ClinicalNational Institutes Of HealthKeratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica
Details
FasinumabSAR-164877; MT-5547; R-475; REGN-475Phase 3 ClinicalAbdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip
Details
MEDI-7352MEDI-7352Phase 2 ClinicalMedimmuneChronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee
Details
N-HexacosanoltCFA15; TAC-302Phase 2 ClinicalMeiji Seika Pharma Co LtdUrinary Bladder, Underactive; Urinary Bladder, Overactive
Details
Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical)Phase 2 ClinicalShenyang Sunshine Pharmaceutical Co LtdBone metastases; Cancer Pain
Details
EP-9001AEP-9001APhase 2 ClinicalChengdu Youluo Biotechnology Co LtdBone metastases; Cancer Pain; Pain
Details
DS-002DS-002Phase 2 ClinicalDartsbio Pharmaceuticals LtdPain; Cancer Pain
Details
AtinumabNG-101; ATI-355Phase 2 ClinicalNovartis Pharma AgSpinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis
Details
SSS-40SSS-40; SSS-40-anti-NGF Ab; SSS40 anti-NGF AbPhase 1 Clinical3sbio IncCancer Pain; Bone Neoplasms; Osteoarthritis
Details
LuvagrobartAK-115Phase 1 ClinicalZhongshan Akeso Biopharma Co LtdPain; Cancer Pain
Details
TNM-009TNM-009; TNM009Phase 1 ClinicalZhuhai Trinomab Pharmaceutical Co LtdCancer Pain; Pain
Details
SMR-7694SMR-7694; SMR7694Phase 1 ClinicalSinobioway Biomedicine Co LtdOsteoarthritis
Details
Neuroregenerative agents (iNtRON Biotechnology)ClinicalIntron BiotechnologyNervous System Diseases
Details
  • Product List
  • Clinical Drug Information